pyrazinobutazone

Known as: 4-butyl-1,2-diphenyl-3,5-pyrazolidinedione cpd with piperazine, pyrasanone, pyrazinobutazon 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1971-1992
02419711992

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
Agranulocytosis and liver injury is described in a patient with Reiter's syndrome of 3 years duration who received… (More)
Is this relevant?
1980
1980
The effect of prednisolone and non-steroid anti-inflammatory drugs on PMNL (polymorphonuclear leucocytes) oxidative metabolism… (More)
Is this relevant?
1978
1978
The rate of absorption of phenylbutazone from pyrazinobutazone (Ranoroc/Carudol) capsules is distinctly lower than that from… (More)
Is this relevant?
1976
1976
Oedema due to postoperative or post-traumatic infection or injury is noted in odontostomatological patients and its symptoms… (More)
Is this relevant?
1976
1976
300 mg/day phenylbutazone, 210 mg/day indomethacin, and 600 mg/day pyrasanone were administered for 14 days to three randomised… (More)
Is this relevant?
1975
1975
Objective and instrumental appraisal of the therapeutic effect of a new inflammatory molecule (pyrasanone) via radio-isotope and… (More)
Is this relevant?